Researchers at Boston University School of Medicine (BUSM) have uncovered important clues about a biochemical pathway in the brain that may one day expand treatment options for schizophrenia. The study, published online in the journal Molecular Pharmacology, was led by faculty within the department of pharmacology and experimental therapeutics at BUSM. Patients with schizophrenia suffer from a life-long condition that can produce delusions, disordered thinking, and breaks with reality...
More...
More...